RenovoRx, Inc.
For the period ended Dec 31, 2024. Filed Apr 1, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 1, 2025
RNXT$1.18+4.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
(in thousands)
| Years Ended December 31, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Cash flows from operating activities: | ||||
| Net loss | $(8,814) | $(10,232) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation expense | 1,174 | 1,078 | ||
| Change in fair value of common stock warrants classified as a liability | (1,772) | (1,709) | ||
| Non-cash lease expense | 7 | - | ||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | (160) | 633 | ||
| Other assets | (221) | (101) | ||
| Accounts payables | 25 | 27 | ||
| Accrued expenses | 636 | 46 | ||
| Net cash used in operating activities | (9,125) | (10,258) | ||
| Cash flows from investing activities: | ||||
| Proceeds from the sale of investments | - | 2,032 | ||
| Purchase of property and equipment | (12) | - | ||
| Net cash (used in) provided by investing activities | (12) | 2,032 | ||
| Cash flows from financing activities: | ||||
| Proceeds from common stock and pre-funded common stock warrants | 15,016 | 5,000 | ||
| Proceeds from exercise of stock options | 69 | 8 | ||
| Proceeds from exercise of common stock warrants | 33 | - | ||
| Net cash provided by financing activities | 15,118 | 5,008 | ||
| Net increase (decrease) in cash and cash equivalents | 5,981 | (3,218) | ||
| Cash and cash equivalents: | ||||
| Beginning of year | 1,173 | 4,391 | ||
| End of year | $7,154 | $1,173 | ||
| Supplemental Disclosure of Cash Flow Information: | ||||
| Cash paid for income taxes | $2 | $38 | ||
| Cash paid for interest | $21 | $14 | ||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | ||||
| Fair value of common stock warrant classified as a liability | $ | - | $3,291 | |
| Right-of-use assets obtained in exchange for lease obligations | $285 | $ | - | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.